Indications: This product has been shown to be effective for the vaccination of healthy cattle, including pregnant cows, against infectious bovine rhinotracheitis (IBR), bovine virus diarrhea types 1 and 2 (BVD1 & BVD2), parainfluenza 3 (PI3), bovine respiratory syncytial virus (BRSV), Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity has not been determined. For more information regarding efficacy and safety data go to productdata. aphis.usda.gov.
This product has also been shown to be effective against urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis) in heifers 10 months of age or older. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure. Directions and dosage: Mix well before use. Inject one 5 mL dose intramuscularly or subcutaneously using aseptic technique. See specific product label for dosage information.
Repeat in 14 to 28 days. Protect animals from exposure for at least 14 days after the last dose of vaccine. Contact your veterinarian or the manufacturer for information on revaccination frequency.
Precautions: Store out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Transient swelling may occur at the injection site. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician. Preservatives: Gentamicin, neomycin, polymyxin B, and thimerosal.
